Bd E-z Scrub 107 Solution
NDC Package 17271-107-03
Package Information
Bd E-z Scrub 107 (chlorhexidine gluconate) solution is a medication used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. This formulation utilizes a solution delivery system. Marketed by Becton Dickinson And Company, this product is identified by NDC 17271-107 and is authorized under FDA application ANDA072525.
Identification & Billing
- RxCUI: 1233682 - BD E-Z Scrub 4 % Medicated Liquid Soap
- RxCUI: 1233682 - chlorhexidine gluconate 40 MG/ML Medicated Liquid Soap [E-Z Scrub]
- RxCUI: 1233682 - E-Z Scrub 107 4 % Medicated Liquid Soap
- RxCUI: 1233682 - E-Z Scrub 40 MG/ML Medicated Liquid Soap
- RxCUI: 211365 - chlorhexidine gluconate 4 % Medicated Liquid Soap
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 17271 - Becton Dickinson And Company
- 17271-107 - Bd E-z Scrub 107
- 17271-107-03 - 10 CARTON in 1 BOX / 30 PACKAGE in 1 CARTON / 18 mL in 1 PACKAGE
- 17271-107 - Bd E-z Scrub 107
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 17271-107-03 identifies a specific commercial package of 10 carton in 1 box / 30 package in 1 carton / 18 ml in 1 package of Bd E-z Scrub 107, a human over the counter drug labeled by Becton Dickinson And Company. This solution is formulated for topical use and contains chlorhexidine gluconate as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Becton Dickinson And Company on October 24, 1989. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used along with regular tooth brushing/flossing to treat gingivitis, a gum disease that causes red, swollen, and easily bleeding gums. Chlorhexidine belongs to a class of drugs known as antimicrobials. It works by decreasing the amount of bacteria in the mouth, helping to reduce swelling and redness of the gums and bleeding when you brush.
How is this Becton Dickinson And Company product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 17271010703. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.